Royalty Pharma plc
RPRX
Rang in aandelen
#860
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Aandeelprijs
$62.20
Laatst gesynchroniseerd: 2026-10-21
Marktkapitalisatie
$27.69B
Verandering (1 dag)
-0.09%
Verandering (1 jaar)
68.82%
Land
US
Handel Royalty Pharma plc (RPRX)
Categorie
Healthcare
Koersgeschiedenis voor Royalty Pharma plc (RPRX)
Hoogste slotkoers: $58.70 op 2026-10-01
Laagste slotkoers: $49.50 op 2020-06-01
Laagste slotkoers: $49.50 op 2020-06-01
Koersgeschiedenis van Royalty Pharma plc van 2020 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 27.37% |
| 2025 | 52.96% |
| 2024 | -9.35% |
| 2023 | -31.53% |
| 2022 | 5.51% |
| 2021 | -14.39% |
| 2020 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $45.90 | 36.68% |
SE
|
|
| $171.71 | 24.15% |
FR
|
|
| $114.97 | 56.10% |
US
|
|
| $59.52 | -0.48% |
IT
|
|
| $0.63 | -31.50% |
HK
|
